Key Record Dates
| ClinicalTrials.gov Identifier: | NCT04926831 |
|---|---|
| Brief Title: | Phase II of Neoadjuvant and Adjuvant Capmatinib in NSCLC (Geometry-N) |
| First Submitted : | June 14, 2021 |
| First Submitted that Met QC Criteria : | June 14, 2021 |
| First Posted : | June 15, 2021 |
| Last Update Submitted that Met QC Criteria : | December 13, 2023 |
| Last Update Posted : | December 14, 2023 |